Another Ozempic weight loss drug competitor is getting a major stock boost ...Middle East

The race is on to break up the current weight loss drug duopoly held by Novo Nordisk, the manufacturer of Ozempic and Wegovy, and Eli Lilly, the maker of Zepbound.Read more...

Hence then, the article about another ozempic weight loss drug competitor is getting a major stock boost was published today ( Tuesday 27/02/2024 - 07:01 PM ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Another Ozempic weight loss drug competitor is getting a major stock boost )

Also on site :

• HMRC apologises after glitch shuts helplines ahead of self-assessment deadline
• New Education Event for Designers, Architects, Builders, and Structural Engineers to Earn Credits and Connect with the Structural Building Components Industry
• Inside OpenAI’s Raid on Thinking Machines Lab